2019-nCoV Envelope protein (N-His&Avi) (STJP000024) STJP000024-100|產品目錄|代理商|上海91麻豆福利视频网生物科技有限公司

所在位置: 首頁> 產品目錄> S類> ST john's laboratory>

查看大圖

產品名稱：2019-nCoV Envelope protein (N-His&Avi) (STJP000024)
產品型號：STJP000024-100
產品廠商：ST john's laboratory
產品文檔：

你添加了1件商品查看購物車

簡單介紹：

2019-nCoV Envelope protein (N-His&Avi) (STJP000024)

詳情介紹：

Host:	E. coli
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	2019-nCoV Envelope-N-His&Avi protein was developed from e. coli and has a target region of N-His&Avi. For use in research applications.

Formulation:	Supplied as a 0.22 Mu m filtered solution in 20mM TRIS, 250mM NaCl, 0.5%TritonX-100, pH 8.0. Contact us for customized product form or formulation.
Immunoreactivity:	Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2 Mu g/mL (100 Mu L/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL.

Immunogen Region:	Met1-Val75
Immunogen:	Recombinant SARS-CoV-2 (2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2 (2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Av

Background

Recombinant SARS-CoV-2 (2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2 (2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

姓名：

電話：

您的需求：

產品名稱：2019-nCoV Envelope protein (N-His&amp;Avi) (STJP000024)

產品名稱：2019-nCoV Envelope protein (N-His&Avi) (STJP000024)